Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Robaeys

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trialÖzgür M Koc, Philippe de Smedt, Cécile Kremer, et al.
Transfusion|May 6, 2021
Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migrationNiels De Brier, Özgür M Koc, Emmy De Buck, et al.
Annals of Hepatology|December 26, 2025
Is FIB-4 the right tool for screening for liver fibrosis?Leen Jm Heyens, Demi P A van Malde, Gediz Dogay Us, et al.
Harm Reduction Journal|October 13, 2021
Hepatitis C reinfection in former and active injecting drug users in BelgiumDana Busschots, Rob Bielen, Özgür M Koc, et al.
Biomedicines|November 27, 2025
Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The NetherlandsLeen J M Heyens, Francesco Innocenti, Christophe Van Steenkiste, et al.
Infectious Diseases and Therapy|May 7, 2017
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational StudyGeert Robaeys, Stefan Christensen, Damien Lucidarme, et al.
BMC Public Health|August 21, 2021
On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA eraDana Busschots, Rob Bielen, Özgür M Koc, et al.
Harm Reduction Journal|May 18, 2021
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, BelgiumDana Busschots, Cécile Kremer, Rob Bielen, et al.
BMC Infectious Diseases|February 29, 2020
Eliminating viral hepatitis C in Belgium: the micro-elimination approachDana Busschots, Samira Toghanian, Rob Bielen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 21, 2021
The hepatitis C cascade of care in the Belgian HIV population: One step closer to eliminationDana Busschots, Cécile Kremer, Özgür M Koc, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trialÖzgür M Koc, Philippe de Smedt, Cécile Kremer, et al.
Transfusion|May 6, 2021
Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migrationNiels De Brier, Özgür M Koc, Emmy De Buck, et al.
Annals of Hepatology|December 26, 2025
Is FIB-4 the right tool for screening for liver fibrosis?Leen Jm Heyens, Demi P A van Malde, Gediz Dogay Us, et al.
Harm Reduction Journal|October 13, 2021
Hepatitis C reinfection in former and active injecting drug users in BelgiumDana Busschots, Rob Bielen, Özgür M Koc, et al.
Biomedicines|November 27, 2025
Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The NetherlandsLeen J M Heyens, Francesco Innocenti, Christophe Van Steenkiste, et al.
Infectious Diseases and Therapy|May 7, 2017
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational StudyGeert Robaeys, Stefan Christensen, Damien Lucidarme, et al.
BMC Public Health|August 21, 2021
On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA eraDana Busschots, Rob Bielen, Özgür M Koc, et al.
Harm Reduction Journal|May 18, 2021
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, BelgiumDana Busschots, Cécile Kremer, Rob Bielen, et al.
BMC Infectious Diseases|February 29, 2020
Eliminating viral hepatitis C in Belgium: the micro-elimination approachDana Busschots, Samira Toghanian, Rob Bielen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 21, 2021
The hepatitis C cascade of care in the Belgian HIV population: One step closer to eliminationDana Busschots, Cécile Kremer, Özgür M Koc, et al.
Pageof 6